Stock listing
885823 Stock Price, News, Filings & Events — Gilead Sciences, Inc.
Selected listing: 885823 · LSX · EUR · DE
This page tracks Gilead Sciences, Inc.'s 885823:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 885823:LSX. 885823:LSX is the stock-level entry point for investors researching Gilead Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gilead Sciences, Inc. is a publicly traded biotechnology company based in the United States, with a market capitalization of approximately $160.5 billion. The company focuses on discovering, developing, and commercializing innovative medicines in areas such as HIV, liver diseases, oncology, and inflammatory diseases. Gilead is committed to advancing healthcare through its research and development efforts.
- Ticker
- 885823:LSX
- Asset type
- Stock
- Market cap
- $180.64B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Gilead Sciences, Inc. 885823:LSX stock context
This page tracks Gilead Sciences, Inc.'s 885823:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 885823:LSX. 885823:LSX is the stock-level entry point for investors researching Gilead Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gilead Sciences, Inc. is a publicly traded biotechnology company based in the United States, with a market capitalization of approximately $160.5 billion. The company focuses on discovering, developing, and commercializing innovative medicines in areas such as HIV, liver diseases, oncology, and inflammatory diseases. Gilead is committed to advancing healthcare through its research and development efforts.
Latest news from Gilead Sciences, Inc.
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those...
August 27, 2026
Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
August 26, 2026
European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status
August 24, 2026
CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results
August 4, 2026
Gilead Sciences : Statement on California Supreme Court Decision in TDF Litigation
August 3, 2026
Gilead Sciences, Inc. earnings calls
Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Gilead Sciences, Inc. (GILD) Q4 2025 Earnings Call
February 10, 2026 · Replay with transcript and chapters
Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Gilead Sciences, Inc. (GILD) Q1 2025 Earnings Call
April 24, 2025 · Replay with transcript and chapters
Research Gilead Sciences, Inc.
Gilead Sciences, Inc. investor report
Review AI stock analysis and investor report context for 885823:LSX.
Gilead Sciences, Inc. company profile
View the public company page for Gilead Sciences, Inc. on 6ix.
Gilead Sciences, Inc. news
Read company news and market updates connected to Gilead Sciences, Inc..
Gilead Sciences, Inc. investor events
Find investor webinars, events, and replay context for Gilead Sciences, Inc..
Alternate listings
GILD:NASDAQ
US · USD
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GIS:GETTEX
DE · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GIS:TRADEGATE
DE · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GILD:BCBA
AR · ARS
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GILD:TSX
CA · CAD
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GIS:XETR
DE · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GILD:NEO
CA · CAD
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
1GILD:MIL
IT · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GILD:BMV
MX · MXN
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
885823:LS
DE · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GIS:FWB
DE · EUR
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.
GILDD:BCBA
AR · USD
Alternate listing for Gilead Sciences, Inc.; the primary context on this page is 885823:LSX.